nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ERBB2—meningioma	0.878	1	CbGaD
Afatinib—PHKG2—brainstem—meningioma	0.00143	0.0824	CbGeAlD
Afatinib—ERBB4—brainstem—meningioma	0.00128	0.0741	CbGeAlD
Afatinib—DYRK1A—brainstem—meningioma	0.00124	0.0713	CbGeAlD
Afatinib—PHKG2—medulla oblongata—meningioma	0.000996	0.0574	CbGeAlD
Afatinib—ERBB4—medulla oblongata—meningioma	0.000896	0.0516	CbGeAlD
Afatinib—ERBB4—spinal cord—meningioma	0.000799	0.046	CbGeAlD
Afatinib—HIPK4—brain—meningioma	0.000751	0.0433	CbGeAlD
Afatinib—PHKG2—cerebellum—meningioma	0.000704	0.0406	CbGeAlD
Afatinib—ERBB2—cerebellum—meningioma	0.000633	0.0365	CbGeAlD
Afatinib—ERBB4—cerebellum—meningioma	0.000633	0.0365	CbGeAlD
Afatinib—DYRK1A—cerebellum—meningioma	0.00061	0.0351	CbGeAlD
Afatinib—EPHA6—brain—meningioma	0.000593	0.0342	CbGeAlD
Afatinib—PHKG2—brain—meningioma	0.000572	0.033	CbGeAlD
Afatinib—ABL1—brainstem—meningioma	0.000538	0.031	CbGeAlD
Afatinib—EGFR—cerebellum—meningioma	0.000537	0.031	CbGeAlD
Afatinib—ERBB4—brain—meningioma	0.000514	0.0297	CbGeAlD
Afatinib—ERBB2—brain—meningioma	0.000514	0.0297	CbGeAlD
Afatinib—DYRK1A—brain—meningioma	0.000495	0.0285	CbGeAlD
Afatinib—IRAK1—cerebellum—meningioma	0.000474	0.0273	CbGeAlD
Afatinib—EGFR—brain—meningioma	0.000436	0.0251	CbGeAlD
Afatinib—IRAK1—brain—meningioma	0.000385	0.0222	CbGeAlD
Afatinib—ABL1—medulla oblongata—meningioma	0.000375	0.0216	CbGeAlD
Afatinib—ABL1—spinal cord—meningioma	0.000335	0.0193	CbGeAlD
Afatinib—ABL1—cerebellum—meningioma	0.000265	0.0153	CbGeAlD
Afatinib—ABCG2—medulla oblongata—meningioma	0.000237	0.0136	CbGeAlD
Afatinib—ABL1—brain—meningioma	0.000216	0.0124	CbGeAlD
Afatinib—ABCG2—spinal cord—meningioma	0.000211	0.0122	CbGeAlD
Afatinib—ABCG2—cerebellum—meningioma	0.000167	0.00965	CbGeAlD
Afatinib—ABCG2—brain—meningioma	0.000136	0.00784	CbGeAlD
Afatinib—ABCB1—medulla oblongata—meningioma	0.000117	0.00673	CbGeAlD
Afatinib—ABCB1—spinal cord—meningioma	0.000104	0.006	CbGeAlD
Afatinib—ABCB1—cerebellum—meningioma	8.25e-05	0.00476	CbGeAlD
Afatinib—ABCB1—brain—meningioma	6.7e-05	0.00386	CbGeAlD
Afatinib—LCK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	6.69e-05	0.000637	CbGpPWpGaD
Afatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—meningioma	6.66e-05	0.000634	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—PTEN—meningioma	6.64e-05	0.000632	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—PTEN—meningioma	6.61e-05	0.000629	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—PTEN—meningioma	6.51e-05	0.00062	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	6.51e-05	0.00062	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—PTEN—meningioma	6.51e-05	0.00062	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—PTEN—meningioma	6.45e-05	0.000614	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—PTEN—meningioma	6.4e-05	0.000609	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—PTEN—meningioma	6.38e-05	0.000608	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SMO—meningioma	6.38e-05	0.000608	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TP53—meningioma	6.38e-05	0.000607	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—PTEN—meningioma	6.37e-05	0.000606	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	6.36e-05	0.000605	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALAD—meningioma	6.29e-05	0.000599	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SMO—meningioma	6.29e-05	0.000599	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—ERBB2—meningioma	6.27e-05	0.000597	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—PTEN—meningioma	6.25e-05	0.000595	CbGpPWpGaD
Afatinib—EGFR—PI-3K cascade—AKT1—meningioma	6.25e-05	0.000595	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TSHB—meningioma	6.14e-05	0.000585	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—TP53—meningioma	6.13e-05	0.000583	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PGR—meningioma	6.12e-05	0.000583	CbGpPWpGaD
Afatinib—EGFR—PI3K/AKT activation—AKT1—meningioma	6.1e-05	0.000581	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—HES1—meningioma	6.08e-05	0.000579	CbGpPWpGaD
Afatinib—LCK—B Cell Receptor Signaling Pathway—AKT1—meningioma	6.07e-05	0.000578	CbGpPWpGaD
Afatinib—EGFR—GAB1 signalosome—AKT1—meningioma	6.05e-05	0.000576	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD34—meningioma	6.04e-05	0.000575	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PGR—meningioma	6.03e-05	0.000574	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—PTEN—meningioma	6.03e-05	0.000574	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ERBB2—meningioma	6.02e-05	0.000574	CbGpPWpGaD
Afatinib—LCK—PI-3K cascade—AKT1—meningioma	6.02e-05	0.000573	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	5.98e-05	0.00057	CbGpPWpGaD
Afatinib—ERBB2—Disease—HES1—meningioma	5.97e-05	0.000569	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—PDGFB—meningioma	5.97e-05	0.000569	CbGpPWpGaD
Afatinib—EGFR—ErbB1 downstream signaling—AKT1—meningioma	5.91e-05	0.000563	CbGpPWpGaD
Afatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	5.91e-05	0.000563	CbGpPWpGaD
Afatinib—PHKG2—Disease—PTEN—meningioma	5.89e-05	0.000561	CbGpPWpGaD
Afatinib—ERBB4—Disease—HES1—meningioma	5.88e-05	0.00056	CbGpPWpGaD
Afatinib—LCK—PI3K/AKT activation—AKT1—meningioma	5.88e-05	0.00056	CbGpPWpGaD
Afatinib—LCK—GAB1 signalosome—AKT1—meningioma	5.83e-05	0.000555	CbGpPWpGaD
Afatinib—LCK—Immune System—CD34—meningioma	5.82e-05	0.000554	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ERBB2—meningioma	5.79e-05	0.000552	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—PLAU—meningioma	5.79e-05	0.000552	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	5.77e-05	0.000549	CbGpPWpGaD
Afatinib—EGFR—Immune System—CTSL—meningioma	5.76e-05	0.000548	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—ERBB2—meningioma	5.72e-05	0.000544	CbGpPWpGaD
Afatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	5.7e-05	0.000543	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—TP53—meningioma	5.56e-05	0.00053	CbGpPWpGaD
Afatinib—LCK—Immune System—CTSL—meningioma	5.55e-05	0.000528	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PDGFB—meningioma	5.53e-05	0.000527	CbGpPWpGaD
Afatinib—ERBB2—Signaling by NGF—AKT1—meningioma	5.49e-05	0.000522	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PDGFB—meningioma	5.45e-05	0.000519	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—PTEN—meningioma	5.43e-05	0.000517	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TSHB—meningioma	5.43e-05	0.000517	CbGpPWpGaD
Afatinib—ERBB4—Signaling by NGF—AKT1—meningioma	5.41e-05	0.000515	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—ERBB2—meningioma	5.4e-05	0.000514	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—PDGFB—meningioma	5.38e-05	0.000512	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—PTEN—meningioma	5.35e-05	0.000509	CbGpPWpGaD
Afatinib—BLK—Immune System—PDGFB—meningioma	5.24e-05	0.000499	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—TP53—meningioma	5.24e-05	0.000499	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—SMO—meningioma	5.22e-05	0.000497	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—PTEN—meningioma	5.22e-05	0.000497	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—ERBB2—meningioma	5.2e-05	0.000495	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—AKT1—meningioma	5.17e-05	0.000493	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—PTEN—meningioma	5.14e-05	0.000489	CbGpPWpGaD
Afatinib—ERBB2—Disease—PDGFB—meningioma	5.11e-05	0.000486	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	5.08e-05	0.000483	CbGpPWpGaD
Afatinib—ERBB4—Disease—PDGFB—meningioma	5.03e-05	0.000479	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—PTEN—meningioma	4.94e-05	0.00047	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—PTEN—meningioma	4.93e-05	0.00047	CbGpPWpGaD
Afatinib—LCK—Hemostasis—PDGFB—meningioma	4.92e-05	0.000468	CbGpPWpGaD
Afatinib—EGFR—Disease—CST3—meningioma	4.91e-05	0.000467	CbGpPWpGaD
Afatinib—ABL1—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.89e-05	0.000466	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—ERBB2—meningioma	4.89e-05	0.000465	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TP53—meningioma	4.81e-05	0.000458	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—AKT1—meningioma	4.79e-05	0.000456	CbGpPWpGaD
Afatinib—LCK—Hemostasis—PLAU—meningioma	4.77e-05	0.000454	CbGpPWpGaD
Afatinib—LCK—Disease—CST3—meningioma	4.73e-05	0.00045	CbGpPWpGaD
Afatinib—EGFR—Signaling by SCF-KIT—AKT1—meningioma	4.67e-05	0.000445	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SMO—meningioma	4.61e-05	0.000439	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—ERBB2—meningioma	4.6e-05	0.000438	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—PTEN—meningioma	4.6e-05	0.000438	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PDGFB—meningioma	4.59e-05	0.000437	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—AKT1—meningioma	4.5e-05	0.000429	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling of activated FGFR—AKT1—meningioma	4.47e-05	0.000426	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—PTEN—meningioma	4.44e-05	0.000422	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PDGFB—meningioma	4.43e-05	0.000421	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PGR—meningioma	4.42e-05	0.000421	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—AKT1—meningioma	4.42e-05	0.000421	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PDGFB—meningioma	4.41e-05	0.00042	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—AKT1—meningioma	4.4e-05	0.000419	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.34e-05	0.000413	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	4.33e-05	0.000412	CbGpPWpGaD
Afatinib—LCK—Downstream signaling of activated FGFR—AKT1—meningioma	4.31e-05	0.00041	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	4.29e-05	0.000408	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PDGFB—meningioma	4.25e-05	0.000405	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—AKT1—meningioma	4.24e-05	0.000404	CbGpPWpGaD
Afatinib—EGFR—Downstream signal transduction—AKT1—meningioma	4.2e-05	0.0004	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HES1—meningioma	4.18e-05	0.000398	CbGpPWpGaD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.18e-05	0.000398	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR—AKT1—meningioma	4.18e-05	0.000398	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB2—AKT1—meningioma	4.16e-05	0.000396	CbGpPWpGaD
Afatinib—EGFR—DAP12 signaling—AKT1—meningioma	4.14e-05	0.000394	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HES1—meningioma	4.12e-05	0.000392	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	4.08e-05	0.000388	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—ERBB2—meningioma	4.08e-05	0.000388	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—AKT1—meningioma	4.06e-05	0.000387	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—TSHB—meningioma	4.05e-05	0.000386	CbGpPWpGaD
Afatinib—LCK—Downstream signal transduction—AKT1—meningioma	4.05e-05	0.000385	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR—AKT1—meningioma	4.03e-05	0.000384	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB2—AKT1—meningioma	4.01e-05	0.000382	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PDGFB—meningioma	4e-05	0.000381	CbGpPWpGaD
Afatinib—LCK—DAP12 signaling—AKT1—meningioma	3.99e-05	0.00038	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—AKT1—meningioma	3.97e-05	0.000378	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	3.93e-05	0.000374	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—PTEN—meningioma	3.93e-05	0.000374	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—AKT1—meningioma	3.89e-05	0.000371	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR in disease—AKT1—meningioma	3.89e-05	0.000371	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	3.89e-05	0.000371	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—AKT1—meningioma	3.86e-05	0.000367	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—AKT1—meningioma	3.83e-05	0.000364	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—AKT1—meningioma	3.81e-05	0.000363	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	3.76e-05	0.000358	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—AKT1—meningioma	3.75e-05	0.000357	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—AKT1—meningioma	3.75e-05	0.000357	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	3.75e-05	0.000357	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—AKT1—meningioma	3.72e-05	0.000354	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—AKT1—meningioma	3.69e-05	0.000351	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—AKT1—meningioma	3.68e-05	0.00035	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—AKT1—meningioma	3.67e-05	0.000349	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	3.66e-05	0.000349	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ERBB2—meningioma	3.65e-05	0.000348	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TSHB—meningioma	3.63e-05	0.000346	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—AKT1—meningioma	3.6e-05	0.000343	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—ERBB2—meningioma	3.6e-05	0.000343	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PDGFB—meningioma	3.58e-05	0.000341	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—AKT1—meningioma	3.54e-05	0.000337	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PDGFB—meningioma	3.52e-05	0.000336	CbGpPWpGaD
Afatinib—BLK—Immune System—ERBB2—meningioma	3.51e-05	0.000335	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TSHB—meningioma	3.5e-05	0.000333	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—ERBB2—meningioma	3.49e-05	0.000332	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—AKT1—meningioma	3.47e-05	0.000331	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	3.45e-05	0.000328	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALAD—meningioma	3.4e-05	0.000324	CbGpPWpGaD
Afatinib—PHKG2—Disease—AKT1—meningioma	3.39e-05	0.000323	CbGpPWpGaD
Afatinib—ERBB4—Disease—ERBB2—meningioma	3.37e-05	0.000321	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	3.32e-05	0.000316	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	3.21e-05	0.000306	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PTEN—meningioma	3.16e-05	0.000301	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—AKT1—meningioma	3.14e-05	0.000299	CbGpPWpGaD
Afatinib—ABL1—Immune System—PDGFB—meningioma	3.13e-05	0.000298	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—AKT1—meningioma	3.13e-05	0.000298	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PTEN—meningioma	3.12e-05	0.000297	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SMO—meningioma	3.09e-05	0.000294	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—AKT1—meningioma	3.08e-05	0.000294	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—ERBB2—meningioma	3.08e-05	0.000293	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—PTEN—meningioma	3.07e-05	0.000293	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HES1—meningioma	3.02e-05	0.000288	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—AKT1—meningioma	3.01e-05	0.000286	CbGpPWpGaD
Afatinib—BLK—Immune System—PTEN—meningioma	3e-05	0.000285	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SMO—meningioma	2.97e-05	0.000283	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—ERBB2—meningioma	2.97e-05	0.000282	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—AKT1—meningioma	2.96e-05	0.000282	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PGR—meningioma	2.96e-05	0.000282	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ERBB2—meningioma	2.96e-05	0.000281	CbGpPWpGaD
Afatinib—ERBB2—Disease—PTEN—meningioma	2.92e-05	0.000278	CbGpPWpGaD
Afatinib—EGFR—Disease—HES1—meningioma	2.89e-05	0.000275	CbGpPWpGaD
Afatinib—ERBB4—Disease—PTEN—meningioma	2.88e-05	0.000274	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PGR—meningioma	2.85e-05	0.000271	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ERBB2—meningioma	2.85e-05	0.000271	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—AKT1—meningioma	2.85e-05	0.000271	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—AKT1—meningioma	2.84e-05	0.000271	CbGpPWpGaD
Afatinib—LCK—Disease—HES1—meningioma	2.78e-05	0.000265	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ERBB2—meningioma	2.68e-05	0.000255	CbGpPWpGaD
Afatinib—EGFR—Immune System—PDGFB—meningioma	2.68e-05	0.000255	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—AKT1—meningioma	2.65e-05	0.000253	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PTEN—meningioma	2.63e-05	0.00025	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PDGFB—meningioma	2.59e-05	0.000246	CbGpPWpGaD
Afatinib—LCK—Immune System—PDGFB—meningioma	2.58e-05	0.000245	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—AKT1—meningioma	2.56e-05	0.000243	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PTEN—meningioma	2.53e-05	0.000241	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PTEN—meningioma	2.52e-05	0.00024	CbGpPWpGaD
Afatinib—EGFR—Disease—PDGFB—meningioma	2.47e-05	0.000235	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PTEN—meningioma	2.43e-05	0.000231	CbGpPWpGaD
Afatinib—LCK—Disease—PDGFB—meningioma	2.38e-05	0.000227	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—ERBB2—meningioma	2.36e-05	0.000225	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TP53—meningioma	2.33e-05	0.000222	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PTEN—meningioma	2.29e-05	0.000218	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—AKT1—meningioma	2.26e-05	0.000215	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TSHB—meningioma	2.19e-05	0.000209	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	2.19e-05	0.000209	CbGpPWpGaD
Afatinib—ABL1—Immune System—ERBB2—meningioma	2.1e-05	0.0002	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PTEN—meningioma	2.05e-05	0.000195	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HES1—meningioma	2.02e-05	0.000193	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PTEN—meningioma	2.01e-05	0.000192	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—AKT1—meningioma	2e-05	0.000191	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—AKT1—meningioma	1.97e-05	0.000187	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HES1—meningioma	1.95e-05	0.000186	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TP53—meningioma	1.92e-05	0.000183	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.85e-05	0.000176	CbGpPWpGaD
Afatinib—ERBB2—Immune System—AKT1—meningioma	1.82e-05	0.000174	CbGpPWpGaD
Afatinib—ERBB4—Immune System—AKT1—meningioma	1.8e-05	0.000171	CbGpPWpGaD
Afatinib—EGFR—Immune System—ERBB2—meningioma	1.79e-05	0.000171	CbGpPWpGaD
Afatinib—ABL1—Immune System—PTEN—meningioma	1.79e-05	0.00017	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—AKT1—meningioma	1.77e-05	0.000169	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ERBB2—meningioma	1.73e-05	0.000165	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDGFB—meningioma	1.73e-05	0.000165	CbGpPWpGaD
Afatinib—LCK—Immune System—ERBB2—meningioma	1.73e-05	0.000165	CbGpPWpGaD
Afatinib—BLK—Immune System—AKT1—meningioma	1.73e-05	0.000164	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—AKT1—meningioma	1.71e-05	0.000163	CbGpPWpGaD
Afatinib—ERBB2—Disease—AKT1—meningioma	1.68e-05	0.00016	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDGFB—meningioma	1.67e-05	0.000159	CbGpPWpGaD
Afatinib—ERBB4—Disease—AKT1—meningioma	1.66e-05	0.000158	CbGpPWpGaD
Afatinib—EGFR—Disease—ERBB2—meningioma	1.66e-05	0.000158	CbGpPWpGaD
Afatinib—LCK—Hemostasis—AKT1—meningioma	1.62e-05	0.000154	CbGpPWpGaD
Afatinib—LCK—Disease—ERBB2—meningioma	1.6e-05	0.000152	CbGpPWpGaD
Afatinib—EGFR—Immune System—PTEN—meningioma	1.53e-05	0.000146	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—AKT1—meningioma	1.51e-05	0.000144	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTEN—meningioma	1.48e-05	0.000141	CbGpPWpGaD
Afatinib—LCK—Immune System—PTEN—meningioma	1.47e-05	0.00014	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—AKT1—meningioma	1.46e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—AKT1—meningioma	1.45e-05	0.000138	CbGpPWpGaD
Afatinib—EGFR—Disease—PTEN—meningioma	1.41e-05	0.000134	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—AKT1—meningioma	1.4e-05	0.000133	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TP53—meningioma	1.4e-05	0.000133	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TP53—meningioma	1.37e-05	0.000131	CbGpPWpGaD
Afatinib—LCK—Disease—PTEN—meningioma	1.36e-05	0.00013	CbGpPWpGaD
Afatinib—IRAK1—Immune System—AKT1—meningioma	1.32e-05	0.000125	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AKT1—meningioma	1.18e-05	0.000112	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AKT1—meningioma	1.16e-05	0.000111	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ERBB2—meningioma	1.16e-05	0.00011	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ERBB2—meningioma	1.12e-05	0.000106	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTEN—meningioma	1.1e-05	0.000105	CbGpPWpGaD
Afatinib—ABL1—Immune System—AKT1—meningioma	1.03e-05	9.82e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TP53—meningioma	1.01e-05	9.61e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTEN—meningioma	9.89e-06	9.41e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AKT1—meningioma	9.65e-06	9.18e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTEN—meningioma	9.53e-06	9.07e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—AKT1—meningioma	8.81e-06	8.39e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AKT1—meningioma	8.52e-06	8.11e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—AKT1—meningioma	8.49e-06	8.09e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—AKT1—meningioma	8.14e-06	7.75e-05	CbGpPWpGaD
Afatinib—LCK—Disease—AKT1—meningioma	7.84e-06	7.47e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TP53—meningioma	6.75e-06	6.42e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TP53—meningioma	6.5e-06	6.19e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AKT1—meningioma	6.36e-06	6.06e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTEN—meningioma	5.97e-06	5.68e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AKT1—meningioma	5.7e-06	5.42e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AKT1—meningioma	5.49e-06	5.23e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AKT1—meningioma	3.44e-06	3.27e-05	CbGpPWpGaD
